Differential regeneration of myocardial infarction depending on the progression of disease and the composition of biomimetic hydrogel

Journal of Bioscience and Bioengineering

Volumn 118, Issue 4, 2014, Pages 461-468

  Yoon, So Jeong ^a,c   Hong, Soyoung ^a   Fang, Yong Hu ^a   Song, Myeongjin ^a   Son, Kuk Hui ^b   Son, Ho Sung ^a   Kim, Sook Kyoung ^a   Sun, Kyung ^a   Park, Yongdoo ^a  

^a Korea University   (South Korea)

^b Gachon University   (South Korea)

^c Bioland Ltd   (South Korea)

Author keywords

Chronic myocardial infarction; Heart function; Hyaluronic acid; Injectable hydrogel; Molecular weight; Tissue regeneration

Indexed keywords

BIOMIMETICS; CARDIOLOGY; HEART; HYALURONIC ACID; MOLECULAR WEIGHT; ORGANIC ACIDS; TISSUE; TISSUE REGENERATION;

HEART FUNCTION; HISTOLOGICAL ANALYSIS; INJECTABLE HYDROGELS; LEFT ANTERIOR DESCENDING; MYOCARDIAL INFARCTION; MYOCARDIAL INFRACTION; REGENERATION ACTIVITY; REGENERATION PROCESS;

HYDROGELS;

HYALURONIC ACID; BIOMIMETIC MATERIAL; CARDIOTONIC AGENT; HYDROGEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HEART INFARCTION; HEART MUSCLE; HYDROGEL; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MOLECULAR WEIGHT; NONHUMAN; RAT; TISSUE REGENERATION; ACUTE DISEASE; ANIMAL; CHEMISTRY; CHRONIC DISEASE; CONVALESCENCE; DISEASE MODEL; DRUG EFFECTS; HEART; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; REGENERATION; SPRAGUE DAWLEY RAT; TIME;

RATTUS;

ACUTE DISEASE; ANIMALS; BIOMIMETIC MATERIALS; CARDIOTONIC AGENTS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; HEART; HYALURONIC ACID; HYDROGELS; MALE; MOLECULAR WEIGHT; MYOCARDIAL INFARCTION; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; REGENERATION; TIME FACTORS;

EID: 84921635115     PISSN: 13891723     EISSN: 13474421     Source Type: Journal    
DOI: 10.1016/j.jbiosc.2014.04.001     Document Type: Article

References (45)

1. Premaratne G.U., Tambara K., Fujita M., Lin X., Kanemitsu N., Tomita S., Sakaguchi G., Nakajima H., Ikeda T., Komeda M. Repeated implantation is a more effective cell delivery method in skeletal myoblast transplantation for rat myocardial infarction. Circ. J. 2006, 70:1184-1189.
2. Hahn J.Y., Cho H.J., Kang H.J., Kim T.S., Kim M.H., Chung J.H., Bae J.W., Oh B.H., Park Y.B., Kim H.S. Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. J.Am. Coll. Cardiol. 2008, 51:933-943.
3. Chachques J.C., Duarte F., Cattadori B., Shafy A., Lila N., Chatellier G., Fabiani J.N., Carpentier A.F. Angiogenic growth factors and/or cellular therapy for myocardial regeneration: a comparative study. J.Thorac. Cardiovasc. Surg. 2004, 128:245-253.
4. Hoffman A.S. Hydrogels for biomedical applications. Adv. Drug. Deliv. Rev. 2002, 54:3-12.
5. Fujita M., Ishihara M., Morimoto Y., Simizu M., Saito Y., Yura H., Matsui T., Takase B., Hattori H., Kanatani Y., Kikuchi M., Maehara T. Efficacy of photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2 in a rabbit model of chronic myocardial infarction. J.Surg. Res. 2005, 126:27-33.
6. Kim J., Kim I.S., Cho T.H., Lee K.B., Hwang S.J., Tae G., Noh I., Lee S.H., Park Y., Sun K. Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells. Biomaterials 2007, 28:1830-1837.
7. Virag J.I., Murry C.E. Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair. Am. J. Pathol. 2003, 163:2433-2440.
8. Li R.K., Mickle D.A., Weisel R.D., Rao V., Jia Z.Q. Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury. Ann. Thorac. Surg. 2001, 72:1957-1963.
9. Schoenfelder M., Einspanier R. Expression of hyaluronan synthases and corresponding hyaluronan receptors is differentially regulated during oocyte maturation in cattle. Biol. Reprod. 2003, 69:269-277.
10. Bremer F.M., Rasquin F. Histochemical localization of hyaluronic acid in vitreous during embryonic development. Invest. Ophthalmol. Vis. Sci. 1998, 39:2466-2469.
11. Itano N., Atsumi F., Sawai T., Yamada Y., Miyaishi O., Senga T., Hamaguchi M., Kimata K. Abnormal accumulation of hyaluronan matrix diminishes contact inhibition of cell growth and promotes cell migration. Proc. Natl. Acad. Sci. USA 2002, 99:3609-3614.
12. Angeli S., Connell S., Gibson B., Ozdek A., McElveen J.T., Van De Water T.R. Injectable form of cross-linked hyaluronan is effective for middle ear wound healing. Ann. Otol. Rhinol. Laryngol. 2007, 116:667-673.
13. Anderson I. The properties of hyaluronan and its role in wound healing. Prof. Nurse 2001, 17:232-235.
14. Slevin M., Kumar S., Gaffney J. Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses. J.Biol. Chem. 2002, 277:41046-41059.
15. Slevin M., Krupinski J., Gaffney J., Matou S., West D., Delisser H., Savani R.C., Kumar S. Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways. Matrix Biol. 2007, 26:58-68.
16. Toole B.P. Hyaluronan: from extracellular glue to pericellular cue. Nat. Rev. Cancer 2004, 4:528-539.
17. Ariyoshi W., Takahashi T., Kanno T., Ichimiya H., Takano H., Koseki T., Nishihara T. Mechanisms involved in enhancement of osteoclast formation and function by low molecular weight hyaluronic acid. J.Biol. Chem. 2005, 280:18967-18972.
18. Lokeshwar V.B., Selzer M.G. Differences in hyaluronic acid-mediated functions and signaling in arterial, microvessel, and vein-derived human endothelial cells. J.Biol. Chem. 2000, 275:27641-27649.
19. Kaneko T., Saito H., Toya M., Satio T., Nakahara K., Hiroi M. Hyaluronic acid inhibits apoptosis in granulosa cells via CD44. J.Assist. Reprod. Genet. 2000, 17:162-167.
20. Deed R., Rooney P., Kumar P., Norton J.D., Smith J., Freemont A.J., Kumar S. Early-response gene signalling is induced by angiogenic oligosaccharides of hyaluronan in endothelial cells. Inhibition by non-angiogenic, high-molecular-weight hyaluronan. Int. J. Cancer 1997, 71:251-256.
21. West D.C., Kumar S. Hyaluronan and angiogenesis. Ciba Found. Symp. 1989, 143:187-201. discussion 201-187, 281-185.
22. Funakoshi T., Majima T., Iwasaki N., Suenaga N., Sawaguchi N., Shimode K., Minami A., Harada K., Nishimura S. Application of tissue engineering techniques for rotator cuff regeneration using a chitosan-based hyaluronan hybrid fiber scaffold. Am. J. Sports Med. 2005, 33:1193-1201.
23. Kato T., Haro H., Komori H., Shinomiya K. Evaluation of hyaluronic acid sheet for the prevention of postlaminectomy adhesions. Spine J. 2005, 5:479-488.
24. Pitarresi G., Palumbo F.S., Calabrese R., Craparo E.F., Giammona G. Crosslinked hyaluronan with a protein-like polymer: novel bioresorbable films for biomedical applications. J.Biomed. Mater. Res. A 2008, 84:413-424.
25. Lepidi S., Grego F., Vindigni V., Zavan B., Tonello C., Deriu G.P., Abatangelo G., Cortivo R. Hyaluronan biodegradable scaffold for small-caliber artery grafting: preliminary results in an animal model. Eur. J. Vasc. Endovasc. Surg. 2006, 32:411-417.
26. Fang J.Y., Chen J.P., Leu Y.L., Hu J.W. Temperature-sensitive hydrogels composed of chitosan and hyaluronic acid as injectable carriers for drug delivery. Eur. J. Pharm. Biopharm. 2008, 68:626-636.
27. He C., Kim S.W., Lee D.S. In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery. J.Control. Release 2008, 127:189-207.
28. Ruel-Gariepy E., Leroux J.C. In situ-forming hydrogels-review of temperature-sensitive systems. Eur. J. Pharm. Biopharm. 2004, 58:409-426.
29. Wright B., Cave R.A., Cook J.P., Khutoryanskiy V.V., Mi S., Chen B., Leyland M., Connon C.J. Enhanced viability of corneal epithelial cells for efficient transport/storage using a structurally modified calcium alginate hydrogel. Regen. Med. 2012, 7:295-307.
30. Chin K., Khattak S.F., Bhatia S.R., Roberts S.C. Hydrogel-perfluorocarbon composite scaffold promotes oxygen transport to immobilized cells. Biotechnol. Prog. 2008, 24:358-366.
31. Kim M.S., Park M.J., Moon E.J., Kim S.J., Lee C.H., Yoo H., Shin S.H., Song E.S., Lee S.H. Hyaluronic acid induces osteopontin via the phosphatidylinositol 3-kinase/Akt pathway to enhance the motility of human glioma cells. Cancer Res. 2005, 65:686-691.
32. Park Y., Yoon S.J., Fang Y.H., Lim C.H., Kim B.S., Sun K. Effects of VEGF loaded hyaluronic acid based hydrogels on ischemic heart regeneration. Tissue Eng. 2007, 13:1683.
33. Song M., Jang H., Lee J., Kim J.H., Kim S.H., Sun K., Park Y. Regeneration of chronic myocardial infarction by injectable hydrogels containing stem cell homing factor SDF-1 and angiogenic peptide Ac-SDKP. Biomaterials 2014, 35:2436-2445.
34. Fukushima S., Varela-Carver A., Coppen S.R., Yamahara K., Felkin L.E., Lee J., Barton P.J., Terracciano C.M., Yacoub M.H., Suzuki K. Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model. Circulation 2007, 115:2254-2261.
35. Hu X., Wang J., Chen J., Luo R., He A., Xie X., Li J. Optimal temporal delivery of bone marrow mesenchymal stem cells in rats with myocardial infarction. Eur. J. Cardiothorac. Surg. 2007, 31:438-443.
36. Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B., Pickel J., McKay R., Nadal-Ginard B., Bodine D.M., Leri A., Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410:701-705.
37. Furuta A., Miyoshi S., Itabashi Y., Shimizu T., Kira S., Hayakawa K., Nishiyama N., Tanimoto K., Hagiwara Y., Satoh T., other 3 authors Pulsatile cardiac tissue grafts using a novel three-dimensional cell sheet manipulation technique functionally integrates with the host heart, in vivo. Circ. Res. 2006, 98:705-712.
38. Huang N.F., Yu J., Sievers R., Li S., Lee R.J. Injectable biopolymers enhance angiogenesis after myocardial infarction. Tissue Eng. 2005, 11:1860-1866.
39. Toole B.P. Hyaluronan-CD44 interactions in cancer: paradoxes and possibilities. Clin. Cancer Res. 2009, 15:7462-7468.
40. Park D., Kim Y., Kim H., Kim K., Lee Y.S., Choe J., Hahn J.H., Lee H., Jeon J., Choi C., Kim Y.M., Jeoung D. Hyaluronic acid promotes angiogenesis by inducing RHAMM-TGFbeta receptor interaction via CD44-PKCdelta. Mol. Cells 2012, 33:563-574.
41. Noble P.W. Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol. 2002, 21:25-29.
42. Longaker M.T., Chiu E.S., Adzick N.S., Stern M., Harrison M.R., Stern R. Studies in fetal wound healing. V. A prolonged presence of hyaluronic acid characterizes fetal wound fluid. Ann. Surg. 1991, 213:292-296.
43. Chen W.Y., Abatangelo G. Functions of hyaluronan in wound repair. Wound Repair Regen. 1999, 7:79-89.
44. Arnold F., Jia C., He C., Cherry G.W., Carbow B., Meyer-Ingold W., Bader D., West D.C. Hyaluronan, heterogeneity, and healing: the effects of ultrapure hyaluronan of defined molecular size on the repair of full-thickness pig skin wounds. Wound Repair Regen. 1995, 3:299-310.
45. Hwang M.W., Matsumori A., Furukawa Y., Ono K., Okada M., Iwasaki A., Hara M., Miyamoto T., Touma M., Sasayama S. Neutralization of interleukin-1beta in the acute phase of myocardial infarction promotes the progression of left ventricular remodeling. J.Am. Coll. Cardiol. 2001, 38:1546-1553.